Skip to main content

Table 1 Model parameters

From: Innovation in health economic modelling of service improvements for longer-term depression: demonstration in a local health community

Parameter

Value

Evidence source and type

Epidemiological

Length of untreated episode of recurrent depression

3rd episode: 0.55 years.

[32] 10 year observational study

 

4th episode: 0.60 years

 
 

5th episode +: 0.43 years

 

Probability of no future recurrence of depression

2 prior episodes: 0.3.

[33]

 

3+ prior episodes: 0.1

 

Time to relapse

0.93 years

[34] 15 year observational study

Clinical presentation

Probability of presenting to services during depressive episode

0.40

[35] Consensus document

Probability of no relapse after cognitive behavioural therapy (CBT) response

0.75

[36] Randomised controlled trial

Primary care

Probability of medical therapy (even if stepping up)

Assumed 100%

Clinical expert assumption

Probability of response after 8 weeks of mirtazapine anti-depressant therapy

0.63

[3, 37] NICE Clinical Guideline

Probability of IAPT referral

Assumed 100%

Clinical expert assumption

IAPT

Probability of low intensity IAPT

0.68

SHSC data

Probability of high intensity IAPT

0.32

 

Probability of effective low intensity IAPT (> 10 point improvement in PHQ9)

0.24

 

Probability of effective high intensity IAPT (> 10 point improvement in PHQ9)

0.54

 

Probability of completing low intensity IAPT

0.35

 

Probability of completing high intensity IAPT

0.35

 

Number of low intensity IAPT sessions

3 + 1 assessment

 

Number of high intensity IAPT sessions

7 + 1 assessment

 

Length of course of low intensity IAPT

0.42 years

 

Length of course of high intensity IAPT

0.71 years

 

Community Mental Health Teams

Time from referral to assessment

0.08 years (4 weeks)

Clinical expert opinion

Probability of accepted at assessment

0.8

 

Treatment effectiveness

CMHT treatment effectiveness assumed equal to IAPT

 

Specialist Psychotherapy Services

Probability of being accepted at SPS assessment

0.71

SHSC data

Treatment effectiveness

SPS treatment effectiveness assumed equal to IAPT

Clinical expert opinion

Costs

GP

£38

2009 NHS Unit Costs

IAPT Therapist (per session)

£88

2010 NHS Reference Cost

CMHT Assessment

£212

 

CMHT Therapist (per session)

£135

 

SPS Assessment

£139

 

SPS Therapist (per session)

£139

 

Mirtazapine treatment. 30 mg daily, 8 week course which if effective is maintained

£4.08 per course

BNF 61

Health Utilities

Untreated severe depression

0.30

[3, 38] NICE Clinical Guideline/Cohort analysis

In health service, severe depression

0.58

 

Minimal depression/normal health

0.85